Last step
in surgery,
first step
in healing™
Advancing patient outcomes through proprietary technologies that set new standards in acute surgical care and regenerative medicine.
Dedicated to better
patient outcomes
Headquartered in Salt Lake City, Utah, Kairos Biosciences is guided by a mission to enhance surgical recovery. We provide innovative solutions that improve patient outcomes and set new standards in acute surgical care.
Our products bring advanced surgical wound care to the patients who need it most, including community hospitals, LTACHs, VA/DoD facilities, and wound care centers across the country.
Two platforms,
one mission
A Type I collagen matrix powder featuring proprietary AngioReef™ technology with an 80–120 µm pore structure that supports vascularization. Designed for use in high-risk surgical wound environments.
Learn More
A silicone-backed antimicrobial foam dressing containing PHMB (Polyhexamethylene Biguanide) for post-operative and high-risk wound management.
Learn MoreWhy Kairos Biosciences?
AngioReef™ technology and PHMB antimicrobials are engineered for high-complexity wound environments with distinct formulation and delivery characteristics.
Every product decision starts with the patient. We target the highest-risk settings: complex surgical wounds, LTACHs, VA/DoD facilities, and wound care centers.
We're building a pipeline of next-generation surgical wound care solutions and looking for partners who want to grow with us, not just move product.
No bureaucracy, no committees. We move fast, think differently, and bring innovations to market while larger companies are still in review cycles.
Ready to grow
your wound care portfolio?
Partner with Kairos Biosciences and gain access to proprietary science, procurement advantages, and a dedicated support team built for your success.